IRIS Accounts Production v25.1.4.42 SC680030 director 1.1.24 31.12.24 31.12.24 21.7.25 0 0 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6800302023-12-31SC6800302024-12-31SC6800302024-01-012024-12-31SC6800302022-12-31SC6800302023-01-012023-12-31SC6800302023-12-31SC680030ns15:Scotland2024-01-012024-12-31SC680030ns14:PoundSterling2024-01-012024-12-31SC680030ns10:Director12024-01-012024-12-31SC680030ns10:PrivateLimitedCompanyLtd2024-01-012024-12-31SC680030ns10:SmallEntities2024-01-012024-12-31SC680030ns10:Audited2024-01-012024-12-31SC680030ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-31SC680030ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-31SC680030ns10:FullAccounts2024-01-012024-12-31SC680030ns10:RegisteredOffice2024-01-012024-12-31SC680030ns5:CurrentFinancialInstruments2024-12-31SC680030ns5:CurrentFinancialInstruments2023-12-31SC680030ns5:ShareCapital2024-12-31SC680030ns5:ShareCapital2023-12-31SC680030ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31SC680030ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: SC680030 (Scotland)















Audited Financial Statements for the Year Ended 31 December 2024

for

Signature Medical Glasgow Ltd

Signature Medical Glasgow Ltd (Registered number: SC680030)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Signature Medical Glasgow Ltd

Company Information
for the Year Ended 31 December 2024







DIRECTOR: Dr S Sainudeen





REGISTERED OFFICE: C/O Lindsays
100 Queen Street
Glasgow
G1 3DN





REGISTERED NUMBER: SC680030 (Scotland)





INDEPENDENT AUDITORS: Haines Watts
Statutory Auditor
3rd Floor Pacific Chambers
11-13 Victoria Street
Liverpool
Merseyside
L2 5QQ

Signature Medical Glasgow Ltd (Registered number: SC680030)

Statement of Financial Position
31 December 2024

31.12.24 31.12.23
Notes £ £
CURRENT ASSETS
Debtors 4 1,807,421 1,153,457

CREDITORS
Amounts falling due within one year 5 427,462 93,943
NET CURRENT ASSETS 1,379,959 1,059,514
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,379,959

1,059,514

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,379,859 1,059,414
1,379,959 1,059,514

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 July 2025 and were signed by:





Dr S Sainudeen - Director


Signature Medical Glasgow Ltd (Registered number: SC680030)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Signature Medical Glasgow Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is generated through the provision of surgical procedures. Transactions are initially recognised at cost, less the deposit paid by the customer, value added tax and other sales taxes, and is recognised at the point the procedures is performed.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Statement of Financial Position when the company becomes party to the contractual provision of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Signature Medical Glasgow Ltd (Registered number: SC680030)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Basic financial assets
Basic financial assets, which include trade and other receivables and cash and cash equivalents, are initially measured at transaction price, including transaction costs, and are then subsequently carried at amortised cost using the effective interest method, less provision for impairment, unless arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future lease receipts discounted at a market rate of interest

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets
Financial assets are assessed for indicators of impairment at each reporting date.

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying value amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial Liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of its liabilities.

Basic financial instruments, which include trade and other payables and bank loans are initially measured at their transaction price after transaction costs. When this constitute a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets
Financial assets are derecognised when their contractual right to future cash flows expire, or are settled, or when the company transfers the asset and substantially all of the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire, are discharged or cancelled.

Signature Medical Glasgow Ltd (Registered number: SC680030)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Amounts owed by group undertakings 1,807,321 1,153,357
Other debtors 100 100
1,807,421 1,153,457

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Taxation and social security 427,462 93,943

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Michael Forshaw BA FCA (Senior Statutory Auditor)
for and on behalf of Haines Watts

7. RELATED PARTY DISCLOSURES

Exemption has been taken from disclosing transactions between wholly owned group companies. No transactions have been undertaken with any non-wholly owned group companies or related parties.

8. ULTIMATE CONTROLLING PARTY

Signature Medical Glasgow Ltd is a subsidiary of Signature Medical Limited. The smallest group for which consolidated financial statements are drawn up of which Signature Medical Glasgow Ltd is a member is SS Medical Holdings Limited which has a registered office of 132 Manchester Road, Rochdale, Greater Manchester, England, OL11 4JQ and its registered number is 13692100.